Researchers in Switzerland have engineered an artificial tissue in which human blood stem cells continue to function for several days.
This content was published on
2 minutes
swissinfo.ch/sb
The tissue, developed by scientists from the University of Basel, University Hospital Basel, and the Federal Institute of Technology, Zurich (ETHZ), mimics some of the complex biological properties of natural bone marrow niches.
Billions of blood cells are produced every day in human bone marrow. This constant supply is ensured by blood stem cells located in special niches within the marrow. These stem cells can multiply and mature into red and white blood cells, which then leave the bone marrow and enter the bloodstream.
For several years, researchers have been trying to reproduce natural bone marrow in the laboratory to better understand the mechanisms of blood formation and to develop new therapies – such as for the treatment of leukemia. However, this has proven to be extremely difficult because in conventional in vitro models the blood stem cells lose their ability to multiply and to differentiate into different types of blood cells.
The team now hope their new technique can be used to produce tailor-made solutions and further research possibilities.
“We could use bone and bone marrow cells from patients to create an in vitro model of blood diseases such as leukemia, for example. Importantly, we could do this in an environment that consists exclusively of human cells and which incorporates conditions tailored to the specific individual,” explains Professor Ivan Martin from the Department of Biomedicine at the University of Basel.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss researchers ‘grow’ cartilage from bone marrow stem cells
This content was published on
Under normal conditions the mesenchymal stem/stromal cells from the bone marrow of adults develop into cartilage tissue which then remodels into bone tissue. This is similar to what happens after a fracture, for example. However, the researchers found they could prevent embryonic cartilage from becoming bone tissue by inhibiting the signaling pathway of a specific…
Italian and Swedish researchers win richest Swiss science prize
This content was published on
The Louis-Jeantet Prize for Medicine has been awarded to Antonio Lanzavecchia from the Swiss-Italian University and Christer Betsholtz from the University of Uppsala in Sweden. They will each receive CHF700,000 ($728,221), of which CHF625,000 must be spent on research. Established in 1986, the prize recognises excellence in European biomedical research. The main fields covered include…
This content was published on
Nenad Ban of the federal technology institute ETH Zurich has been selected to receive the Otto Naegeli prize for his work on ribosomes.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.